These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 20432590

  • 1. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
    Fiasse R, Denis MA, Dewit O.
    J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
    [Abstract] [Full Text] [Related]

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 3. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F, Wagner AC, Göke B.
    Schweiz Med Wochenschr; 2000 Feb 19; 130(7):222-32. PubMed ID: 10719713
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C.
    Ther Umsch; 1997 Nov 19; 54(11):649-53. PubMed ID: 9454368
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun 19; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 6. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr 28; 147(17):58-9. PubMed ID: 15903063
    [No Abstract] [Full Text] [Related]

  • 7. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Apr 28; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 8. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P, Van Assche G, Vermeire S.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):451-63. PubMed ID: 16441465
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
    Kruis W, Pohl C.
    Dtsch Med Wochenschr; 1998 Jan 23; 123(4):85-7. PubMed ID: 9487288
    [No Abstract] [Full Text] [Related]

  • 11. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice.
    Tursi A, Elisei W, Brandimarte G, Giorgetti G, Penna A, Castrignano V.
    Eur Rev Med Pharmacol Sci; 2010 Jan 23; 14(1):47-55. PubMed ID: 20184089
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C.
    Clin Pharmacol Ther; 2008 Jan 23; 83(1):70-6. PubMed ID: 17507924
    [Abstract] [Full Text] [Related]

  • 13. Management of inflammatory bowel disease in adults.
    Katz JA.
    J Dig Dis; 2007 May 23; 8(2):65-71. PubMed ID: 17532817
    [Abstract] [Full Text] [Related]

  • 14. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, Bretagne JF.
    Gastroenterol Clin Biol; 1997 May 23; 21(6-7):483-90. PubMed ID: 9295976
    [Abstract] [Full Text] [Related]

  • 15. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 23; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 16. Advances in inflammatory bowel diseases in children.
    Michail S, Ramsy M, Soliman E.
    Minerva Pediatr; 2012 Jun 23; 64(3):257-70. PubMed ID: 22555319
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V, Munkholm P.
    Ugeskr Laeger; 2001 Jan 01; 163(1):16-21. PubMed ID: 11586666
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
    Van Assche G, Vermeire S, Rutgeerts P.
    Curr Opin Gastroenterol; 2009 Jul 01; 25(4):323-8. PubMed ID: 19417645
    [Abstract] [Full Text] [Related]

  • 19. First-line therapies in inflammatory bowel disease.
    Girardin M, Manz M, Manser C, Biedermann L, Wanner R, Frei P, Safroneeva E, Mottet C, Rogler G, Schoepfer AM.
    Digestion; 2012 Jul 01; 86 Suppl 1():6-10. PubMed ID: 23051720
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 01; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.